Showing posts with label epithelial ovarian cancer. Show all posts
Showing posts with label epithelial ovarian cancer. Show all posts
Saturday, January 21, 2012
Sunday, August 08, 2010
abstract: How to follow-up patients with epithelial ovarian cancer : Current Opinion in Oncology
How to follow-up patients with epithelial ovarian cancer
Miller, Rowan E; Rustin, Gordon JS
Abstract
Purpose of review: Despite optimal primary treatment most patients with advanced epithelial ovarian cancer will relapse. This review discusses the controversy regarding surveillance and the timing of treatment for recurrent disease.
Recent findings: Routine physical examination has a limited role in the detection of recurrent ovarian cancer. PET/computed tomography (CT) has been shown to be useful in detecting small volume disease not apparent on traditional imaging in patients with suspected recurrence based on symptoms and/or rising CA125. The results of PET/CT can alter treatment plans and have particular use in guiding site-directed therapy. The benefits of early detection and systemic treatment of recurrence are now in doubt following the presentation of the MRC/EORTC CA125 surveillance trial. The impact on survival of secondary cytoreductive surgery requires more investigation.
Summary: Uncertainties remain in the surveillance and timing of treatment for relapsed disease. Patients should be informed of these uncertainties and become involved in decisions regarding their follow-up.
add your opinions
10 year followup
,
breast conserving surgery
,
clincial trials
,
CT
,
early detection
,
EORTC
,
epithelial ovarian cancer
,
follow-up
,
MRC
,
patient involvement
,
PET
,
physical examinations
,
surveillance
Subscribe to:
Posts
(
Atom
)